March 2021 | AIChE

You are here

March 2021

Celia Cruz

Celia N. Cruz, Ph.D., is Sr. Director of Process Design and Development for synthetic molecules at Eli Lilly, overseeing late phase chemistry and drug product development and commercialization. Prior to joining Lilly in 2019, Celia was director of the Division of Product Quality Research at the FDA and a member of the Emerging Technology Team.  Before joining the FDA in 2010, Celia was a Principal Development Engineer at Merck, where she led the development and commercialization of multiple drug products...Read more

AIChE Observes Women's History Month

AIChE observes Women's History Month with a weekly series that profiles the careers and industry contributions of women chemical engineers. Look for new posts every week in March.

Alex Pierson

Alex Pierson is the Technical Product Manager for the Access Solutions Group at Beckman Coulter, working to grow the continued success of the Beckman Coulter Access Systems and Biomek Integrated Solutions.  A recent effort includes the new Echo into the Biomek i-Series, a platform which benefits from the strengths of both liquid handlers.

Alex has a Masters Degree in Biology with research in yeast genetics and molecular biology, and continues to leverage his years of experience and customer relationships as an Echo Field Applications Specialist and support of researchers in...Read more

Learn About Sponsors & Exhibitors

The virtual AIChE Spring Meeting & Global Congress on Process Safety will have many ways to connect with sponsors and exhibitors. The exhibit hall, workshops, networking events, giveaways and more gives you opportunities to learn about new technologies and find solutions to the challenges you'...

Douglas Friedman

Douglas Friedman is CEO of BioMADE, the Bioindustrial Manufacturing Innovation Institute, and Executive Director of the Engineering Biology Research Consortium (EBRC). His primary scientific and technical interests lie in the fields of synthetic biology, biomanufacturing, and modern biotechnology. Doug's policy interests include development of sustainable biotechnology, safeguarding the bioeconomy, and accelerating technical advancement by building diverse, robust community partnerships. He regularly serves as a subject matter expert on emerging biotechnologies, biotechnology policy, and...Read more

Pages